Reports
-
Treating Buruli Ulcer: A Review of Prospects for Existing Antibiotics and New Therapeutics
Buruli ulcer disease is a serious necrotizing skin infection caused by the environmental pathogen Mycobacterium ulcerans and represents the third most common mycobacterial infection worldwide after tuberculosis...
Last updated 26 March 2013
www.msfaccess.org/our-work/driving-medical-innovation/article/2026 -
Medical Innovation for Neglected Patients
Over the past half century, there have been unprecedented improvements in health outcomes, spurred in part by unparalleled scientific progress in the pharmaceutical sector. Yet access to the benefits...
Last updated 12 December 2012
www.msfaccess.org/our-work/driving-medical-innovation/article/1959 -
Financing Medical Innovation Through Alternative Mechanisms
How to boost R&D for a low-cost, point-of-care rapid diagnostic test and better drugs for tuberculosis On 11 April 2008, Médecins Sans Frontières (MSF) convened a one-day consultation of tuberculosis...
Last updated 11 April 2008
www.msfaccess.org/our-work/driving-medical-innovation/article/1830 -
Ten Stories that Mattered in Access to Medicines in 2011
Introduction 2011 marks the ten-year anniversary of two events that have helped shape people’s ability in developing countries to access quality, affordable medical care. First, the signing of...
Last updated 20 December 2011
www.msfaccess.org/our-work/driving-medical-innovation/article/1715 -
Five Lives: How a Financial Transaction Tax Could Support Global Health
‘5 Lives’ are the stories of people that MSF works with every day, whose health and lives often hang on a simple medical intervention. These personal experiences are a snapshot of the unnecessary...
Last updated 20 October 2011
www.msfaccess.org/our-work/driving-medical-innovation/article/1650 -
Medical Innovations in Humanitarian Situations
Medical Innovations in Humanitarian Situations explores how the particular style of humanitarian action practiced by Médecins Sans Frontières (MSF) has stayed in line with the standards in scientifically...
Last updated 3 June 2011
www.msfaccess.org/our-work/driving-medical-innovation/article/1610 -
The Global Politics of Pharmaceutical Monopoly Power
Every day, Médecins Sans Frontières (MSF) is confronted with the lack of access to adequate or affordable medical tools in the field. We face two major challenges the high cost of existing medicines...
Last updated 16 January 2009
www.msfaccess.org/our-work/driving-medical-innovation/article/1606 -
Untangling the Web of Antiretroviral Price Reductions: 14th Edition
The latest edition of Untangling the Web of Antiretroviral Price Reductions (UTW) released at the IAS 2011 in Rome demonstrates a growing and deadly divide in antiretroviral (ARV) prices offered to the...
Last updated 18 July 2011
www.msfaccess.org/our-work/driving-medical-innovation/article/1601 -
Giving developing countries the best shot: An overview of vaccine access and R&D
Vaccines have made possible some of the greatest public health successes in the past century.
Last updated 10 May 2010
www.msfaccess.org/our-work/driving-medical-innovation/article/896 -
Cough Up for TB! The Underfunding of TB Research Across Europe (October 2009)
EU member states are not contributing their fair share to research and development for tuberculosis (TB).
Last updated 15 October 2009
www.msfaccess.org/our-work/driving-medical-innovation/article/900
